Lung Function, Exercise Capacity, and Serology Responses in Patients With COVID-19
Recruiting
Observational Study
Lung Function
Exercise Capacity
Quality of Life
Covid19
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 700 (estimated)
- Sponsor
- Chinese University of Hong Kong · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
(a) Objectives
1. To assess the full lung function, exercise capacity, quality of life in patients with COVID-19 over 2 years.
2. To assess the longevity of the serology response to SARS-CoV2.
3. To investigate the association of the neutralization titer in plasma from different vaccinated cohorts to its protection of infection using in vivo model
4. To investigate the SARS-CoV-2 specific cellula…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria: Patients who have been discharged from hospital following treatment for COVID-19 -
Exclusion Criteria: Unwilling to be follow up
\-
Contacts